Catalyst Wire Dossier Catalyst Wire Dossier

VIOKASE16

pancreatic enzyme replacement therapy · Axcan Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIOKASE16, covering 2010-02-11 to 2010-02-11. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) [Phase 2]

See pricing